Patents by Inventor Jane E. Clifford

Jane E. Clifford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210023089
    Abstract: The present invention relates generally to compositions and methods for treating diseases and disorders caused by herpes simplex virus type 1, including herpes simplex keratitis, in a subject. In certain embodiments, the compositions of the present invention comprise an ATM inhibitor and an anti-herpetic agent. In other embodiments, the compositions comprise a Chk2 inhibitor and an anti-herpetic agent. In yet other embodiments, the compositions comprise a Chk2 inhibitor and an ATM inhibitor, and optionally an anti-herpetic agent.
    Type: Application
    Filed: October 6, 2020
    Publication date: January 28, 2021
    Inventors: Jane E. CLIFFORD, Oleg ALEKSEEV, Stephen R. JENNINGS
  • Patent number: 10071098
    Abstract: The present invention relates generally to compositions and methods for treating diseases and disorders caused by herpes simplex virus type 1, including herpes simplex labialis or herpes esophagitis, in a subject. In certain embodiments, the compositions of the invention comprise an ATM inhibitor and an anti-herpetic agent. In other embodiments, the compositions comprise a Chk2 inhibitor and an anti-herpetic agent. In yet other embodiments, the compositions comprise a Chk2 inhibitor and an ATM inhibitor, and optionally an anti-herpetic agent.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: September 11, 2018
    Assignee: Drexel University
    Inventors: Jane E. Clifford, William E. Donegan, Oleg Alekseev
  • Publication number: 20180008609
    Abstract: The present invention relates generally to compositions and methods for treating diseases and disorders caused by herpes simplex virus type 1, including herpes simplex keratitis, in a subject. In certain embodiments, the compositions of the present invention comprise an ATM inhibitor and an anti-herpetic agent. In other embodiments, the compositions comprise a Chk2 inhibitor and an anti-herpetic agent. In yet other embodiments, the compositions comprise a Chk2 inhibitor and an ATM inhibitor, and optionally an anti-herpetic agent.
    Type: Application
    Filed: August 17, 2017
    Publication date: January 11, 2018
    Inventors: Jane E. CLIFFORD, Oleg ALEKSEEV, Stephen R. JENNINGS
  • Publication number: 20170056410
    Abstract: The present invention relates generally to compositions and methods for treating diseases and disorders caused by herpes simplex virus type 1, including herpes simplex keratitis, in a subject. In certain embodiments, the compositions of the present invention comprise an ATM inhibitor and an anti-herpetic agent. In other embodiments, the compositions comprise a Chk2 inhibitor and an anti-herpetic agent. In yet other embodiments, the compositions comprise a Chk2 inhibitor and an ATM inhibitor, and optionally an anti-herpetic agent.
    Type: Application
    Filed: November 9, 2016
    Publication date: March 2, 2017
    Inventors: Jane E. CLIFFORD, Oleg ALEKSEEV, Stephen R. JENNINGS
  • Publication number: 20160089372
    Abstract: The present invention relates generally to compositions and methods for treating diseases and disorders caused by herpes simplex virus type 1, including herpes simplex labialis or herpes esophagitis, in a subject. In certain embodiments, the compositions of the invention comprise an ATM inhibitor and an anti-herpetic agent. In other embodiments, the compositions comprise a Chk2 inhibitor and an anti-herpetic agent. In yet other embodiments, the compositions comprise a Chk2 inhibitor and an ATM inhibitor, and optionally an anti-herpetic agent.
    Type: Application
    Filed: September 24, 2015
    Publication date: March 31, 2016
    Applicant: DREXEL UNIVERSITY
    Inventors: Jane E. Clifford, William E. Donegan, Oleg Alekseev
  • Publication number: 20150080390
    Abstract: The present invention relates generally to compositions and methods for treating diseases and disorders caused by herpes simplex virus type 1, including herpes simplex keratitis, in a subject. In certain embodiments, the compositions of the present invention comprise an ATM inhibitor and an anti-herpetic agent. In other embodiments, the compositions comprise a Chk2 inhibitor and an anti-herpetic agent. In yet other embodiments, the compositions comprise a Chk2 inhibitor and an ATM inhibitor, and optionally an anti-herpetic agent.
    Type: Application
    Filed: September 17, 2014
    Publication date: March 19, 2015
    Inventors: Jane E. Clifford, Oleg Alekseev, Stephen R. Jennings